HER2 affibody-based PET/CT imaging agent
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HER2 affibody-based PET/CT imaging agent, covering 2024-08-23 to 2024-08-23. Get the full timeline:
Most recent: Clinical Trial Update: HER2 Expression of HER2 Affibody-based PET/CT to Predict Response in Bladder Cancer Patients Treated With ADC [NA]